Can progesterone and allopregnanolone affect premenstrual anxiety, insomnia, night sweats, and palpitations?

Premenstrual mood and somatic symptoms often emerge in individuals with normal baseline follicular hormones, highlighting a sophisticated neuroendocrine interface where progesterone-derived neurosteroids regulate central nervous system excitability.

Molecular and receptor mechanisms

• Neurosteroid conversion: Progesterone is metabolized into the neurosteroid allopregnanolone (3α,5α-tetrahydroprogesterone) via the sequential actions of 5-alpha-reductase and 3-alpha-hydroxysteroid dehydrogenase in the brain and peripheral tissues.
• GABA-A modulation: Allopregnanolone acts as a highly potent positive allosteric modulator of GABA-A receptors, particularly targeting extrasynaptic, subunit-containing receptors that govern tonic inhibition.
• Neuronal excitability: At physiological nanomolar concentrations, allopregnanolone binds to specific transmembrane domain cavities to stabilize the open state of the channel and increase chloride ion conductance. This hyperpolarizes membranes and decreases excitability in key emotion-regulating regions like the amygdala and hippocampus, producing robust calming, anxiolytic, and sedative effects. At elevated micromolar concentrations, it can directly gate the channel.

Etiology of premenstrual symptoms

• Altered receptor sensitivity: Premenstrual dysphoric disorder (PMDD) and associated symptoms are primarily driven by abnormal neural sensitivity or a failed adaptation of GABA-A receptors to fluctuating allopregnanolone levels during the luteal phase, rather than abnormal absolute hormone levels. This results in a suboptimal or paradoxical GABAergic response.
• Luteal progesterone deficiency: Inadequate absolute levels of luteal progesterone remain a highly plausible contributor. Lower progesterone levels directly yield decreased concentrations of its downstream calming metabolite, allopregnanolone, which diminishes inhibitory tone and can trigger anxiety and sleep fragmentation.
• Autonomic shifts: Fluctuations in progesterone and its sudden withdrawal can prompt autonomic shifts, directly increase resting heart rate, and activate the renin-angiotensin system (causing fluid retention), triggering or worsening premenstrual palpitations and night sweats.

Bottom line

• Premenstrual anxiety, insomnia, and autonomic symptoms are primarily driven by an abnormal neural sensitivity of GABA-A receptors to luteal allopregnanolone fluctuations, though absolute luteal progesterone deficiency remains a highly plausible exacerbating factor that reduces overall GABAergic calming tone.